News Articles

Mar. 26 2025

Exclusive: Anti-aging mRNA therapy biotech acquires Harvard startup’s microvesicle delivery tech

Dec. 3 2024

Turn Bio commences bone marrow rejuvenation study

June 26 2024

Challenging God: The Rapid Development of Life Science (Translated PDF) [View in original Japanese]

May 29 2024

HanAll Biopharma and Turn Bio to Develop Novel Treatments for Eye and Ear Diseases

May 29 2024

Turn Bio and HanAll to develop therapies for age-related conditions

May 29 2024

Turn Bio signs agreement with Korea's HanAll Biopharma to develop eye and ear therapies

May 28 2024

Turn Bio inks $300m epigenetic reprogramming deal with HanAll Biopharma

May 07 2024

Hacking the immune system could slow ageing — here’s how

Apr. 12 2024

Holistic Rejuvenation – an Integrative Approach

Apr. 4 2024

Skin cells are rejuvenated with medicine. Are the eyes a disease? Immortality approaches. (Translated PDF) [View in original Japanese]

Mar. 17 2024

“Live your whole life as a young person in your 20s”... The world's first ‘rejuvenation drug' is about to be launched (Translated PDF) [View in original Korean]

Jan. 3 2024

Turn Biotechnologies Revolutionizes mRNA Delivery with eTurna Platform Expansion

Dec. 4 2023

Moving RNA Therapeutics Beyond the Liver

May 2 2023

Potential of Epigenetic Reprogramming to Rejuvenate Skin Highlighted at SEASON Aesthetic Conference 2023

Mar. 2023

Epigenome Rejuvenation: Anti-Aging Stem Cell Therapy

Feb. 2023

Turn Biotechnologies: Developing mRNA Medicines to Induce Healing by Instructing Specific Cells to Fight Disease or Repair Damaged Tissue

Dec. 2022

Preliminary Data Proves Turn Biotechnologies' Regenerative Therapies First Ever to Reverse Aging in Human Skin

Dec. 2022

Time to Turn the Other Cheek: Turn Biotechnologies Aims to Change Paradigm in Skin Rejuvenation…

Oct. 2022

Yes, We Will Increase Our Lifespan

Sept. 2022

The Era of Rejuvenation with Cell Rejuvenation Technology, Which Will Only Rise in 5 Years

Sept. 2022

Turn Biotechnologies Launches Delivery System for Nucleic Acid Therapeutics

Sept. 2022

This Follicle-Hacking Drug Could One Day Treat Baldness

Aug. 2022

Dr. Albert Wu to Oversee Turn Biotechnologies Product Development

July 2022

VitaDAO Invests $1 Million into Biotech Company Turn.Bio

May 2022

Reprogramming Cells with Vittorio Sebastiano of Turn.bio

Apr. 2022

Stanford Spinout Racks Up More Support for its mRNA Approach to Cellular Rejuvenation

Apr. 2022

Korean Firms Back US-based Turn Bio for mRNA Therapies

Apr. 2022

Astellas-backed Turn Bio is Advancing Epigenetics for Long, Healthy Life Span

Apr. 2022

In Silicon Valley, Researchers are Working to Reverse Aging.

Jan. 2022

Rejuvenation by Controlled Reprogramming is the Latest Gambit in Anti-Aging

Dec. 2021

Have Scientists Beaten Ageing?

Dec. 2021

On A Quest to Turn Back Time on Age-Related Disease

Apr. 2021

Turn Completes Funding Round for Disruptive Technologies

Jan. 2021

Turn Bio Announce Worldwide IP for mRNA Tech

Apr. 2020

Reprograman células para eliminar los signos del envejecimiento

Mar. 2020

Turning Back the Clock on Aging Cells

Mar. 2020

Old Human Cells Rejuvenated with Stem Cell Technology

2020

Epigenetic Reprogramming of Cellular Aging: a novel paradigm to treat aging and aging-associated diseases

Feb. 2018

Does Aging Have a Reset Button?

2017

Transient reprogramming for efficient cell-autonomous reversal of age-associated phenotypes